Life Sciences

Using Watson to Accelerate Drug Discovery

Share this post:

IBM Watson Health aims to transform the drug development process for life sciences – from research to commercialization. IBM Watson for Drug Discovery helps accelerate breakthroughs by enabling researchers to quickly analyze, identify, and prioritize new therapeutic targets and drug combinations for future study.

Imagine if you could: 

  • Access structured and unstructured data from disparate sources in seconds
  • Quickly uncover novel patterns and connections across domains and therapeutic areas
  • Look beyond the known candidates to predict and generate new hypotheses
  • Focus your time and resources investigating selected targets supported by evidence

Join the webinar: October 13, 2016 at 1-2pm ET

Register now for the webinar, Using Watson to Accelerate Drug Discovery”, to see how Watson can help empower you to make more informed pipeline decisions so that you can accelerate how quickly drugs can reach patients.

Featured Speakers:

  • Van Willis
    IBM Watson Health, Senior Consultant
  • Alix Lacoste
    Data Scientist & Subject Matter Expert, IBM Watson for Drug Discovery
  • Henry Chen
    Product Manager, IBM Watson for Drug Discovery

Global Industry Leader, Healthcare & Life Sciences, Market Segment Management

More Life Sciences stories

The Enormous Potential of AI for Pharmaceutical

The adoption of Artificial Intelligence (AI) in research-intensive organizations has essentially seen linear growth in recent years. Pharmaceutical, CRO, university and healthcare organizations are beginning to shift away from theoretical plans to genuine practical applications of machine intelligence. But what problems are these institutions trying to solve? Dr. Lester Russell, Associate Partner, Clinical Digital Innovation […]

Continue reading